$TNDM on NASDAQ
January 08, 2024
Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor
December 12, 2023
Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers
December 06, 2023
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.
November 06, 2023
Tandem Diabetes Care Announces Upcoming Conference Presentations
November 01, 2023
Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer
November 01, 2023
Tandem Diabetes Care Announces Third Quarter 2023 Financial Results
October 21, 2023
TNDM Shareholder Update: Johnson Fistel Encourages Tandem Diabetes Care Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline
October 10, 2023
Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023
August 24, 2023
Tandem Diabetes Care Announces Upcoming Conference Presentations
August 03, 2023
Tandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi System
August 03, 2023
Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance
August 01, 2023
Tandem Diabetes Care to Present at the UBS MedTech, Tools and Genomics Summit 2023
July 21, 2023
TNDM FRAUD ALERT: Jakubowitz Law is Investigating Tandem Diabetes Care, Inc. in Connection with Potential Violations of Federal Securities Laws
July 17, 2023
TNDM ALERT: The Law Offices of Vincent Wong Investigate Tandem Diabetes Care, Inc. for Potential Violations of Securities Laws
July 14, 2023
TNDM FRAUD ALERT: Jakubowitz Law is Investigating Tandem Diabetes Care, Inc. in Connection with Potential Violations of Federal Securities Laws
July 11, 2023
Tandem Mobi, World’s Smallest Durable Insulin Delivery System, Receives FDA Clearance
July 10, 2023
Tandem Diabetes Care to Announce Second Quarter 2023 Financial Results on August 3, 2023
May 24, 2023
Tandem Diabetes Care to Present at the Jefferies Healthcare Conference
May 03, 2023
Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
April 20, 2023
Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference
April 17, 2023
Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes
April 11, 2023
Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023
March 15, 2023
Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology
February 22, 2023
Tandem Diabetes Care Appoints New Chair of Board of Directors
February 22, 2023
Tandem Diabetes Care Announces Fourth Quarter 2022 Financial Results and Full Year 2023 Financial Guidance
February 15, 2023
Tandem Diabetes Care Announces Upcoming Conference Presentations
January 23, 2023
Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical
January 19, 2023
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
January 10, 2023
Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook
January 03, 2023
Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 13, 2022
Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical
November 16, 2022
Tandem Diabetes Care Earns Great Place to Work Certification™
November 10, 2022
Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology
November 08, 2022
Tandem Diabetes Care Announces Upcoming Conference Presentation
November 02, 2022
Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
October 27, 2022
Tandem Diabetes Care Announces Upcoming Conference Presentations
October 04, 2022
Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022
August 22, 2022
Tandem Diabetes Care Announces Upcoming Conference Presentations
August 18, 2022
Tandem Diabetes Care Achieves Milestone of 1 Million Insulin Boluses Delivered Using Its t:connect Mobile App
August 03, 2022
Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
July 21, 2022
Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical
July 12, 2022
Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022
April 27, 2022
Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults
April 11, 2022
Tandem Diabetes Care to Announce First Quarter 2022 Financial Results on May 4, 2022
March 07, 2022
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation
February 22, 2022
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance
February 16, 2022
Tandem Diabetes Care Announces FDA Clearance for the t:slim X2 Insulin Pump to Bolus Using the t:connect Mobile App
February 11, 2022
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations
January 19, 2022
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2021 Financial Results on February 22, 2022
December 02, 2021
Tandem Diabetes Care Announces Expansion of Senior Leadership Team
- No Recent Filings Found.
